Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2357 of 6351
-
New study aims to cut drug side effects for stomach cancer patients
Symptom relief Recruiting nowImatinib can lead to long recurrence free survival in patients diagnosed with gastrointestinal stromal tumors (GIST); however side effects can significantly hinder quality of life for our patients. This study will use therapeutic drug monitoring to improve quality of life and sym…
Phase 2 • Sponsor: Reema A. Patel • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Could a Van-Mounted MRI bring brain scans to everyone?
Knowledge-focused Recruiting nowBackground: Magnetic resonance imaging (MRI) is a tool for getting pictures of the tissues and organs inside the body. MRI can help diagnose many injuries and diseases. But not all patients are equally likely to receive MRIs. Factors such as race or ethnicity, distance to imagin…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Could your phone diagnose sleep apnea? new trial aims to find out
Diagnosis Recruiting nowThe goal of this clinical trial is to evaluate the effectiveness of the Apneal® app in diagnosing sleep apnea syndrome (SAS) in adults who require polysomnography (PSG) as part of routine care. The main questions it aims to answer are: * Can Apneal® accurately classify the SAS s…
Sponsor: Mitral • Aim: Diagnosis
Last updated Jun 27, 2026 07:52 UTC
-
Obesity drug DA-1726 tested in humans for first time
Disease control Recruiting nowThis is a First in Human study to evaluate the safety and tolerability of DA-1726 following single and multiple doses in participants with obesity, but otherwise healthy subjects.
Phase 1 • Sponsor: NeuroBo Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could qelbree tame ADHD and mood swings in adults?
Disease control CompletedOpen label, flexible dose, decentralized clinical trial evaluating the efficacy and safety of SPN-812 in adults with ADHD and mood symptoms.
Phase 4 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New depression drug shows promise in early trial
Symptom relief CompletedThe goal of this clinical trial is to determine the pharmacodynamic effects of ALTO-203 in patients with MDD in a randomized, placebo-controlled, single-dose crossover treatment period. Additionally, safety, tolerability, and PK will be assessed in a subsequent randomized placebo…
Phase 2 • Sponsor: Alto Neuroscience • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New scope could revolutionize surgery before birth
Knowledge-focused By invitation onlyThe Researchers are trying to determine feasibility and safety of performing surgery in the womb with the Karl Storz fetoscopes (a tool used to access the baby in the body of the mother). This are new and improved fetoscopes that are not yet approved by the FDA.
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Neck injection may restore swallowing in stroke survivors
Disease control CompletedThis is a randomized controlled study, including dysphagic patients with bulbar palsy after ischemic stroke who were received in the department of rehabilitation medicine in 3 hospitals in China. All patients are randomly allocated to the observation group or the control group. B…
Sponsor: Zeng Xi • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
One shot, two protections? study tests combined polio and rotavirus vaccines for infants
Vaccine CompletedThe purpose of this study is to evaluate the immune response and safety of the inactivated poliovirus (IPV) vaccine when co-administered with the human rotavirus (HRV) porcine circovirus (PCV)-free vaccine in healthy Chinese infants 6-10 weeks of age at the time of study enrolmen…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Jun 27, 2026 07:55 UTC
-
Can a 6-Session class keep teens mentally healthy?
Prevention Recruiting nowThis research study aims to develop a brief group-based treatment called Resilience Training for Teens, then to test how well it protects high school students with mild symptoms of depression, anxiety, or having unusual feelings from developing mental illnesses.
Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
New PET scan shows promise for detecting rare tumors
Diagnosis CompletedThe purpose of this study was to evaluate the diagnostic performance of \[68Ga\]Ga-DOTA-TATE Positron Emission Tomography (PET)/Computerized Tomography (CT) imaging compared with conventional imaging (CIM) as standard of truth in patients with neuroendocrine neoplasms (NENs) and …
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
VR treadmill trial aims to help stroke survivors walk and think better
Disease control Recruiting nowThis was a single-blind randomized controlled trial of multisensory stimulation virtual reality to improve motor and cognitive dysfunction in stroke patients.
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can online CBT help veterans at risk for suicide?
Symptom relief Recruiting nowThis study plans to learn more about the use of one of two self-guided online cognitive behavioral therapy courses. One is focused on symptoms of depression and one is focused on history of suicidal thoughts and behaviors.
Phase 2 • Sponsor: VA Eastern Colorado Health Care System • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Squeeze your way to better blood pressure? handgrip exercise tested as a simple solution
Disease control Recruiting nowHypertension is the most important cause of cardiovascular disease (CVD), stroke, and premature death (WHO, 2021). It is estimated by The World Health Organisation in 2021 that 1.4 billion individuals across the globe have high blood pressure, with only 14% of people actively man…
Sponsor: Swansea University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Small wishes, big comfort: new program brings dignity to End-of-Life care
Symptom relief OngoingDignified and compassionate end-of-life (EOL) care is a cornerstone of high-quality, patient-centered care, but in safety-net hospitals EOL care is often overlooked, considered too late, or not at all. By eliciting and implementing final wishes for dying patients, the 3 Wishes Pr…
Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Gene-Guided cancer care: does expert advice change treatment?
Knowledge-focused Recruiting nowThis is a single-arm Phase II study to measure the impact of Molecular Tumor Board treatment recommendations on treatment decision-making in clinical practice at the Dartmouth Cancer Center. Following tumor genetic profiling, subjects will be screened for eligibility. Eligible su…
Phase 2 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Blood inflammation may hold clues to psychiatric diagnosis
Knowledge-focused Recruiting nowMost psychiatric research is based on the nosographic classifications used in current practice. At present, there is no diagnostic or prognostic biomarker for psychiatric pathologies commonly used in clinical practice. The study hypothesis is that peripheral inflammatory biomarke…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
AI could predict which ICU patients with breathing failure are at highest risk of death
Knowledge-focused CompletedAcute hypoxemic respiratory failure (AHRF) is the most common cause of admission in the intensive care units (UCIs) worldwide. We will assess the value of machine learning (ML) techniques for early prediction of ICU death in 1,241 patients enrolled in the PANDORA (Prevalence AND …
Sponsor: Hospital Universitario de Gran Canaria Doctor Negrín • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Could a daily iron pill boost energy in heart failure?
Disease control Recruiting nowThe goal of this study is to investigate the effect of oral sucrosomial iron on exercise capacity and quality of life in patients with heart failure (HF) and iron deficiency (ID). The main question the study aims to answer is whether oral sucrosomial iron improved exercise capac…
Phase 4 • Sponsor: Raffaele De Caterina • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New cancer drug HLX42 enters first human trial
Disease control Recruiting nowThis study is an open-label first-in-human phase I clinical study to evaluate the safety and tolerability of HLX42.
Phase 1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC